Metraipolis › archive › dc_752990fb00d2

Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants — Europe PMC PMID:41614164

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41614164
DOI
10.1021/jacsau.5c01178
License (as archived)
solo-consultazione
Archived
2026-11-06T21:04:01.062Z
SHA-256 of the archived text
00795765089e4e45d21fd6a0e16501b024fd69f01362fa59971fe47c1bc8aa98
Stable URL of this page
https://metraipolis.com/documento/dc_752990fb00d2

How to cite

Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants — Europe PMC PMID:41614164 — Europe PMC (en), https://europepmc.org/article/MED/41614164 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_752990fb00d2 (Metraipolis archive dc_752990fb00d2, sha256 00795765089e4e45d21fd6a0e16501b024fd69f01362fa59971fe47c1bc8aa98)
BibTeX
@misc{dc752990fb00d2,
  title = {Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants — Europe PMC PMID:41614164},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41614164},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_752990fb00d2; sha256 00795765089e4e45d21fd6a0e16501b024fd69f01362fa59971fe47c1bc8aa98},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41614164. Agents can read the archived copy with the MCP tool read_document.